Active learning provides an efficient strategy for molecular property prediction by iteratively prioritizing compounds for experimental evaluation. However, the effectiveness of active learning pipelines depends strongly on the choice of molecular representation, and systematic understanding of how representation families affect the active learning process in terms of uncertainty and predictive performance remains limited. In this work, we introduce ActiveFusion, a framework for integrating heterogeneous molecular representations within active learning workflows for molecular property prediction. The framework enables systematic evaluation of physicochemical descriptors, molecular fingerprints, learned graph neural network (GNN) representations, and pretrained Transformer-based representations, as well as feature-level fusion strategies that combine complementary chemical information sources. ActiveFusion evaluates models across four molecular property prediction regression tasks. Across datasets, we demonstrate that feature fusion between learned graph representations and physicochemical descriptors consistently improves prediction performance and discovery (average final iteration R2 of 0.71, 0.67, and 0.54 for our overall best representations Chemprop+RDKit, Chemprop, and RDKit, respectively). We show that exploration-driven acquisition strategies enhance scaffold coverage and promote sampling of structurally novel regions of chemical space, and that model-agnostic acquisition of new compounds based on diversity has strong performance. Notably, both pretrained and finetuned Transformer-based embeddings do not consistently outperform physicochemical features or GNN-learned representations in our setting, highlighting the continued relevance of chemically interpretable features and learned features from supervised, task-specific models for active learning applications in molecular property prediction. Overall, ActiveFusion provides a systematic framework for studying representation-acquisition interactions in molecular discovery with representation fusion capabilities. Our study offers practical guidance for designing active learning pipelines that balance prediction accuracy with chemical space exploration.
Nelson Evbarunegbe, Shiyun Wa, Luke Taylor et al.· Journal of Chemical Informat...· 0 citations
Virtual screening (VS) on small molecules aims to identify promising drug candidates against protein targets from expansive chemical libraries by balancing the core requirements of accurate scoring and efficient search against the inherent trade‐off between accuracy and speed. This survey provides a comprehensive review of how Artificial Intelligence and Machine Learning (AI/ML) are redefining this landscape across three critical dimensions. First, we examine the evolution of AI‐driven scoring functions, which utilize AI/ML models to capture complex structure–activity relationships from massive biochemical datasets, significantly enhancing structure‐ and ligand‐based evaluations beyond traditional heuristics. Second, we summarize the emergence of efficient search algorithms that iteratively prioritize informative compounds to reduce search efforts by orders of magnitude. Third, we review the paradigm shift toward generative molecular design, making VS transition from screening fixed libraries to the
de novo
generation of molecules optimized for specific structural contexts and multi‐objective properties. This review outlines the transition toward end‐to‐end, adaptive discovery systems that ensure computational hits are biologically potent, structurally optimized, and synthetically accessible.
Yifei Wang, Nupur Bansal, Shiyun Wa et al.· WIREs Computational Molecula...· 0 citations
This work introduces Elite-Weighted Supervised Fine-tuning (EW-SFT), which uses reward to guide elite selection of high-scoring molecules, and updates the model by its own pretraining loss on that set, and consistently outperforms the corresponding native optimizers.
Shiyun Wa, Yifei Wang, A. G. Green et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.